The Economic Footprint of the Pharmaceutical Industry – Regional Breakdown and Differentiation between Originators and Generics

The Economic Footprint of the Pharmaceutical Industry – Regional Breakdown and Differentiation between Originators and Generics

This study independently conducted by WifOR reveals how the pharmaceutical industry, one of the world’s largest industries, plays a major role in boosting the global economy across regions. This study was commissioned by the IFPMA and aims to refine the study on ‘Measuring the economic footprint of the pharmaceutical industry – Feasibility study’ that examined for the first time the global economic importance of the pharma industry.


Please note: That all fields marked with an asterisk (*) are required.